147 related articles for article (PubMed ID: 11908935)
1. Interleukins 2 and 12 produce significant recovery of cytotoxic function in dibutyltin-exposed human natural killer cells.
Whalen MM; Walker L; Loganathan BG
Environ Res; 2002 Feb; 88(2):103-15. PubMed ID: 11908935
[TBL] [Abstract][Full Text] [Related]
2. Interleukins 2 and 12 produce recovery of cytotoxic function in tributyltin-exposed human natural killer cells.
Whalen MM; Williams TB; Green SA; Loganathan BG
Environ Res; 2002 Mar; 88(3):199-209. PubMed ID: 12051798
[TBL] [Abstract][Full Text] [Related]
3. Effect of dibutyltin on ATP levels in human natural killer cells.
Dudimah FD; Gibson C; Whalen MM
Environ Toxicol; 2007 Apr; 22(2):117-23. PubMed ID: 17366562
[TBL] [Abstract][Full Text] [Related]
4. Expression of functionally relevant cell surface markers in dibutyltin-exposed human natural killer cells.
Odman-Ghazi SO; Hatcher F; Whalen MM
Chem Biol Interact; 2003 Jul; 146(1):1-18. PubMed ID: 12902148
[TBL] [Abstract][Full Text] [Related]
5. Brief butyltin exposure induces irreversible inhibition of the cytotoxic function on human natural killer cells, in vitro.
Whalen MM; Green SA; Loganathan BG
Environ Res; 2002 Jan; 88(1):19-29. PubMed ID: 11896664
[TBL] [Abstract][Full Text] [Related]
6. Butyltin exposure causes a rapid decrease in cyclic AMP levels in human lymphocytes.
Whalen MM; Loganathan BG
Toxicol Appl Pharmacol; 2001 Mar; 171(3):141-8. PubMed ID: 11243913
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
Rabinowich H; Herberman RB; Whiteside TL
Cell Immunol; 1993 Dec; 152(2):481-98. PubMed ID: 7903063
[TBL] [Abstract][Full Text] [Related]
8. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.
Sotiriadou NN; Perez SA; Gritzapis AD; Mahaira LG; Salagianni M; Baxevanis CN; Papamichail M
Cell Immunol; 2005 Mar; 234(1):67-75. PubMed ID: 16024007
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis.
Bonnema JD; Rivlin KA; Ting AT; Schoon RA; Abraham RT; Leibson PJ
J Immunol; 1994 Mar; 152(5):2098-104. PubMed ID: 7907631
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
13. Persistent inhibition of human natural killer cell function by ziram and pentachlorophenol.
Taylor TR; Tucker T; Whalen MM
Environ Toxicol; 2005 Aug; 20(4):418-24. PubMed ID: 16007644
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 (IL-12) alone or in synergistic combination with IL-2 for in vitro activation of human bone marrow: differential effects at different time points.
Verma UN; Mazumder A
Bone Marrow Transplant; 1995 Sep; 16(3):365-72. PubMed ID: 8535308
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
Tam YK; Martinson JA; Doligosa K; Klingemann HG
Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
[TBL] [Abstract][Full Text] [Related]
16. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
[TBL] [Abstract][Full Text] [Related]
17. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
18. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of natural killer cells for clinical applications.
Klingemann HG; Martinson J
Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
[TBL] [Abstract][Full Text] [Related]
20. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity.
Nirmala R; Narayanan PR; Mathew R; Maran M; Deivanayagam CN
Tuberculosis (Edinb); 2001; 81(5-6):343-52. PubMed ID: 11800585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
